Hasegawa T, Hirose T, Seki K, Sano T, Hizawa K
First Department of Pathology, University of Tokushima School of Medicine, Japan.
J Pathol. 1993 Jul;170(3):305-10. doi: 10.1002/path.1711700314.
To clarify the nature of neoplastic cells, 17 giant cell tumours of bone were studied histologically and immunohistochemically. L1 antigen and S-100 protein were not detected in the tumour giant cells and stromal cells, although present in non-neoplastic macrophages. The giant cells in all the lesions, some stromal cells, and osteoclasts in the normal bone showed CD68 and transforming growth factor alpha (TGF alpha) immunoreactivity. Fibrohistiocytic antigen, factor XIIIa, was expressed in large numbers of stromal cells in all lesions. Some stromal cells expressed alpha-smooth muscle actin and osteocalcin. These immunohistochemical results suggested that the stromal cells of giant cell tumours of bone showed histiocytic and occasional myofibroblastic and osteoblastic differentiation. Proliferating cell nuclear antigen was demonstrated in the nuclei of the stromal cells only, indicating that these were the sole proliferating elements. TGF alpha produced by the giant cells and some stromal cells may play a role as a mediator for the attraction and/or proliferation of the precursor cells, and may suppress the activity of osteoblastic stromal cells, resulting in restricted bone formation in giant cell tumours.
为明确肿瘤细胞的性质,对17例骨巨细胞瘤进行了组织学和免疫组织化学研究。在肿瘤巨细胞和基质细胞中未检测到L1抗原和S-100蛋白,尽管在非肿瘤性巨噬细胞中存在。所有病变中的巨细胞、部分基质细胞以及正常骨中的破骨细胞均显示CD68和转化生长因子α(TGFα)免疫反应性。纤维组织细胞抗原、因子ⅩⅢa在所有病变的大量基质细胞中表达。部分基质细胞表达α-平滑肌肌动蛋白和骨钙素。这些免疫组织化学结果提示,骨巨细胞瘤的基质细胞表现出组织细胞以及偶尔的肌成纤维细胞和成骨细胞分化。增殖细胞核抗原仅在基质细胞核中显示,表明这些是唯一的增殖成分。巨细胞和部分基质细胞产生的TGFα可能作为前体细胞吸引和/或增殖的介质发挥作用,并可能抑制成骨基质细胞的活性,导致骨巨细胞瘤中骨形成受限。